The performance of the therapeutics segment of the German biotechnology industry has
become a focal case for debate over the usefulness of the varieties of capitalism (henceforth …

Regions with biotechnology-specific knowledge seem to have best chances to attract
potential entrepreneurs to establish a biotechnology-firm. Furthermore, regional oriented …

This chapter argues that modern biotechnology has been–and continues to be–developing
at a rapid pace and is connected to fundamental changes in the economy over time, with …

Based on the MIT experience and that of other US universities, the formation and sustained
existence of biotechnology company clusters are discussed. A cluster's origin and continued …

Over the past three decades, the biotechnology industry has emerged as a vital and
dynamic source of new technologies for the pharmaceutical and agricultural chemical …

This paper builds on a suite of research studies examining the metamorphosis in industry
organisation, as Penrose calls it, regarding the centrality of firm capabilities in biosciences …

This book is aimed at providing a large audience, including practitioners, politicians and
decision-makers, with useful insights in relation to innovation and entrepreneurship in the …

Why do firms in high technology industries cluster at particular locations? Do firms grow
faster at such locations and are disproportionately more new firms created in clusters? The …

The purpose of this study is to create an understanding of the strategies that biotechnology
firms in Sweden implement, how they manage to keep their competence ahead and how …